Corpus Intelligence IC Memo — UPPER VALLEY MEDICAL CENTER 2026-04-26 14:15 UTC
IC Memo — UPPER VALLEY MEDICAL CENTER
Investment Committee Memorandum | OH | 142 beds | Grade C | EBITDA uplift $11.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

UPPER VALLEY MEDICAL CENTER

CCN 360174 | MIAMI, OH | 142 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

UPPER VALLEY MEDICAL CENTER is a 142-bed suburban community hospital in MIAMI, OH with $156.3M in net patient revenue and a 12.0% operating margin. The hospital serves a payer mix of 29.7% Medicare, 4.5% Medicaid, and 65.7% commercial.

Thesis: Turnaround. Our ML models identify $11.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 12.0% to 19.3% (+736bps).

Net Revenue HCRIS$156.3M
Current EBITDA COMPUTED$18.7M
Operating Margin COMPUTED12.0%
Occupancy HCRIS43.1%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS24.0%
Distress Probability ML49.5%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
92
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 12.0% places it above the state median. Among 92 size-comparable peers (71-284 beds), the median margin is 0.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (71-284), prioritizing same-state peers. 92 hospitals in the comp set.

HospitalStateBedsRevenueMargin
UPPER VALLEY MEDICAL CENTER (Target)OH142$156.3M12.0%
RAINBOW BABIES & CHILDRENS HOSOH231$2.22B-5.0%
DAYTON CHILDRENS HOSPITALOH181$569.1M7.9%
GENESIS HEALTHCARE SYSTEMOH282$527.6M0.6%
MARIETTA MEMORIAL HOSPITALOH188$475.8M-12.4%
ADENA REGIONAL MEDICAL CENTEROH209$470.7M3.5%
SOUTHERN OHIO MEDICAL CENTEROH192$424.3M-4.9%
SOUTHWEST GENERAL HEALTH CENTEOH191$406.9M2.5%
MEDCENTRAL HEALTH SYSTEMOH240$382.6M0.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $11.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.3M+210bp18mo
Cost to Collect4.5%2.5%$3.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.9M+122bp9mo
Clean Claim Rate88.0%96.0%$100K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.3M
Cost to Collect
$3.1M
Denial Rate Reduction
$3.1M
A/R Days Reduction
$1.9M
Clean Claim Rate
$100K
Total EBITDA Uplift$11.5M
Current EBITDA$18.7M
+ RCM Uplift+$11.5M
Pro Forma EBITDA$30.2M
Current Margin12.0%
Pro Forma Margin19.3%
WC Released (1x)$6.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$28.8M$238.5M8.28x52.6%
Base (11x exit)10.0x11.0x$28.8M$271.7M9.43x56.6%
Bull Case9.0x11.0x$25.9M$319.0M12.31x65.2%
Bull (12x exit)9.0x12.0x$25.9M$355.7M13.72x68.8%
Bear Case11.0x10.0x$31.7M$171.7M5.42x40.2%
Bear (11x exit)11.0x11.0x$31.7M$199.1M6.28x44.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 92 hospitals with 71-284 beds
  • Same-state prioritization (n=93)
  • Comp margins: P25=-11.1% / P50=0.2% / P75=7.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.